Cascadian Therapeutics, Inc. - FORM 10-Q - EX-32.1 - SECTION 1350 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER.

Attached files

file	filename
EX-31.1 - RULE 13A-14(A) / 15D-14(A) CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER. - Cascadian Therapeutics, Inc.	ex31-1.htm
EX-32.2 - SECTION 1350 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER. - Cascadian Therapeutics, Inc.	ex32-2.htm
EX-31.2 - RULE 13A-14(A) / 15D-14(A) CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER. - Cascadian Therapeutics, Inc.	ex31-2.htm
10-Q - QUARTERLY REPORT - Cascadian Therapeutics, Inc.	casc-10q_063017.htm

Cascadian Therapeutics, Inc. 10-Q

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

I, Scott D. Myers, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Cascadian Therapeutics, Inc. for the quarterly period ended June 30, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Cascadian Therapeutics, Inc.


August 8, 2017	/s/ Scott D. Myers
	Scott D. Myers
	President and Chief Executive Officer
	(Principal Executive Officer)

Attached files

Stock widget

Investing forum

Cascadian Therapeutics, Inc. Reports